Literature DB >> 16762104

Prosocials prefer equal outcomes to maximizing joint outcomes.

Daniel Eek1, Tommy Gärling.   

Abstract

Existing theories of social value orientations posit that prosocials maximize joint outcomes whereas proselfs maximize outcomes to themselves. Three studies employing a total of 157 undergraduates were conducted to test the alternative hypothesis that prosocials prefer equal outcomes to maximizing joint outcome. In study 1 participants completed the Triple-Dominance Measure of Social Values in which a fourth alternative that distributed the largest joint outcome unequally was added to the alternative that distributed the outcomes equally. In accordance with the hypothesis, prosocials preferred the equal-outcome alternative to the joint-outcome alternative. Study 2 confirmed and extended these results by demonstrating that prosocials preferred equal outcomes to larger joint outcomes that were unequally distributed but provided both with larger outcomes. Study 3 demonstrated that in a modified prisoner's dilemma game, a preference for equal outcomes to a larger joint outcome resulted in that prosocials cooperated when they believed or knew that the other cooperated, and defected when they believed or knew that the other defected.

Entities:  

Mesh:

Year:  2006        PMID: 16762104     DOI: 10.1348/014466605X52290

Source DB:  PubMed          Journal:  Br J Soc Psychol        ISSN: 0144-6665


  2 in total

1.  Rejection of unfair offers in the ultimatum game is no evidence of strong reciprocity.

Authors:  Toshio Yamagishi; Yutaka Horita; Nobuhiro Mifune; Hirofumi Hashimoto; Yang Li; Mizuho Shinada; Arisa Miura; Keigo Inukai; Haruto Takagishi; Dora Simunovic
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-27       Impact factor: 11.205

2.  People prefer joint outcome prosocial resource distribution towards future others.

Authors:  Yukako Inoue; Toshiyuki Himichi; Nobuhiro Mifune; Tatsuyoshi Saijo
Journal:  Sci Rep       Date:  2021-03-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.